title: Azacitidine as the post-remission therapy for elderly patients with acute myeloid leukemia.
authors.affiliation: Division of Hematology, Department of Internal Medicine, National Hospital Organization Tokyo Medical Center, 2-5-1, Higashigaoka, Meguro-ku, Tokyo, Japan.
authors.forename: Ryusuke
authors.initials: R
authors.lastname: Yamamoto
authors.forename: Akihiro
authors.initials: A
authors.lastname: Yokoyama
authors.forename: Mie
authors.initials: M
authors.lastname: Yoneda
authors.forename: Kota
authors.initials: K
authors.lastname: Ohashi
authors.forename: Toru
authors.initials: T
authors.lastname: Hosoda
authors.forename: Toshiya
authors.initials: T
authors.lastname: Kagoo
authors.forename: Saigen
authors.initials: S
authors.lastname: Boku
authors.forename: Hironori
authors.initials: H
authors.lastname: Ueno
authors.forename: Takahiro
authors.initials: T
authors.lastname: Yano
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001374:Azacitidine / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D060046:Maintenance Chemotherapy; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine